BOOTHBAY FUND MANAGEMENT, LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 69 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$51,000
+121.7%
19,190
+62.6%
0.00%
+50.0%
Q1 2020$23,000
-76.3%
11,800
-14.2%
0.00%
-75.0%
Q4 2019$97,00013,7520.01%
Other shareholders

There were no reported owners of XERIS PHARMACEUTICALS INC in Q1 2020.

NameSharesValueWeighting ↓
View complete list of XERIS PHARMACEUTICALS INC shareholders